Parallax Volatility Advisers
NVCR icon

Parallax Volatility Advisers’s NovoCure NVCR Stock Holding History

Parallax Volatility Advisers’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-31,200
Closed -$488K – 2200
2024
Q1 		$488K Buy
+31,200
New +$459K ﹤0.01% 1414
2023
Q3 		– Sell
-23,000
Closed -$955K – 2504
2023
Q2 		$955K Sell
23,000
-44,200
-66% -$2.74M ﹤0.01% 1418
2023
Q1 		$4.04M Sell
67,200
-276,300
-80% -$22.1M 0.01% 950
2022
Q4 		$25.2M Buy
343,500
+138,400
+67% +$10.4M 0.04% 450
2022
Q3 		$15.6M Buy
205,100
+4,900
+2% +$382K 0.02% 603
2022
Q2 		$13.9M Buy
200,200
+175,300
+704% +$13.2M 0.01% 605
2022
Q1 		$2.06M Sell
24,900
-25,100
-50% -$1.85M ﹤0.01% 1350
2021
Q4 		$3.75M Sell
50,000
-17,600
-26% -$1.77M ﹤0.01% 871
2021
Q3 		$7.85M Sell
67,600
-9,400
-12% -$1.42M 0.01% 727
2021
Q2 		$17.1M Sell
77,000
-292,000
-79% -$56.8M 0.02% 396
2021
Q1 		$48.8M Buy
369,000
+21,900
+6% +$3.46M 0.11% 153
2020
Q4 		$60.1M Buy
347,100
+301,500
+661% +$41.3M 0.06% 261
2020
Q3 		$5.08M Buy
45,600
+19,400
+74% +$1.55M ﹤0.01% 1310
2020
Q2 		$1.56M Buy
26,200
+24,300
+1,279% +$1.6M ﹤0.01% 1559
2020
Q1 		$127K Buy
+1,900
New +$150K ﹤0.01% 2094
2018
Q2 		– Sell
-14,000
Closed -$305K – 2909
2018
Q1 		$305K Sell
14,000
-71,900
-84% -$1.55M ﹤0.01% 1194
2017
Q4 		$1.74M Sell
85,900
-11,000
-11% -$212K ﹤0.01% 969
2017
Q3 		$1.92M Buy
96,900
+71,900
+288% +$1.41M ﹤0.01% 862
2017
Q2 		$433K Hold
25,000
– – ﹤0.01% 1266
2017
Q1 		$203K Buy
+25,000
New +$181K ﹤0.01% 1946
2016
Q4 		– Sell
-25,000
Closed -$213K – 3785
2016
Q3 		$213K Hold
25,000
– – ﹤0.01% 1824
2016
Q2 		$292K Buy
+25,000
New +$313K ﹤0.01% 1668

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Parallax Volatility Advisers's NVCR Position: Q2 2024 in Review

Parallax Volatility Advisers sold out of NovoCure (NVCR) in Q2 2024, closing a stake of 10,183 shares — an estimated $159K sold.

Parallax Volatility Advisers first reported a position in NVCR in Q4 2017 and held it in 11 quarters. The position peaked at $3.69M in Q1 2020. 236 funds tracked by Wall St. Rank hold NVCR as of Q2 2024.

  • Parallax Volatility Advisers reported no remaining NovoCure position as of Q2 2024 after selling out during the quarter.
  • Parallax Volatility Advisers sold 10,183 NovoCure shares in Q2 2024, an estimated $159K.
  • Parallax Volatility Advisers first reported a position in NovoCure in Q4 2017 and held it in 11 quarters.
  • Parallax Volatility Advisers's NovoCure position peaked at $3.69M in Q1 2020.
  • 236 funds tracked by Wall St. Rank held NovoCure as of Q2 2024.

Based on Parallax Volatility Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.